Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure

NCT00663195 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Chronic Stable Heart Failure

Interventions

DRUG: spironolactone + furosemide

Sponsor

Tottori University Hospital